Krafte Douglas 4
4 · Icagen, Inc. · Filed May 1, 2019
Insider Transaction Report
Form 4
Icagen, Inc.NONE
Krafte Douglas
Chief Scientific Officer
Transactions
- Award
Stock Option
2019-04-29+75,267→ 75,267 totalExercise: $3.50From: 2019-04-29Exp: 2029-04-29→ Common Stock (75,267 underlying)
Footnotes (1)
- [F1]These options vest in full immediately upon the date of the grant.